results
GSK to make ‘fundamental changes’
February 6, 2014Sales and Marketing China, GSK, Tafinlar, Witty, q4, results
GlaxoSmithKline has pledged to make ‘fundamental changes’ to the manner in which it does business, looking at its interaction with …
Johnson & Johnson posts strong Q3 results
October 16, 2013Sales and Marketing J&J, JJ, Q3, Velcade, results
Johnson & Johnson has posted a strong set of financials for the third quarter as new products from its pharma …
Novartis’ 2012 results flat
January 24, 2013Sales and Marketing Bexsero, Jakavi, Novartis, generics, results
Generic competition has put a dent in Novartis’ financial results for 2012, with net sales down 3% year on year …
Shire posts strong quarter results
August 2, 2012Sales and Marketing ADHD, Adderall XR, Pfizer, Q2, Shire, results
Shire has posted a set of healthy financials for the second quarter, buoyed by its ADHD and rare drug portfolio. …
MRN posts 533% growth in first five years
August 1, 2012Research and Development clinical trials, growth, results
From humble beginnings in 2006 with six dedicated staff members and a vision to transform clinical trial support, the Medical …
AstraZeneca revenues reach standstill
January 31, 2011Sales and Marketing AstraZeneca, Full year 2010, patent expiry, results
AstraZeneca’s revenues came to a virtual standstill in 2010, with strong growth outside the US being offset by generic competition …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
